Bausch Health Companies Inc. Incremental Common Shares Attributable to Dilutive Effect of Conversion of Debt Securities
Bausch Health Companies Inc. (BHC) reported Incremental Common Shares Attributable to Dilutive Effect of Conversion of Debt Securities of 0 shares for the 12-month period ending 2013-12-31, per its 10-K filed 2014-02-28.
Discontinued › Income Statement › Earnings Per Share
us-gaap:IncrementalCommonSharesAttributableToConversionOfDebtSecurities · last filed 2014-02-28
- Bausch Health Companies Inc. incremental common shares attributable to dilutive effect of conversion of debt securities for the quarter ending 2013-09-30 was 0.00 shares, a 100.00% decline year-over-year.
- Bausch Health Companies Inc. incremental common shares attributable to dilutive effect of conversion of debt securities for the quarter ending 2013-06-30 was 0.00 shares.
- Bausch Health Companies Inc. incremental common shares attributable to dilutive effect of conversion of debt securities for the quarter ending 2012-09-30 was 307.00K shares, a 97.48% decline year-over-year.
- Bausch Health Companies Inc. incremental common shares attributable to dilutive effect of conversion of debt securities for the quarter ending 2012-06-30 was 0.00 shares, a 100.00% decline year-over-year.
- Bausch Health Companies Inc. incremental common shares attributable to dilutive effect of conversion of debt securities for fiscal 2013 was 0.00 shares.
- Bausch Health Companies Inc. incremental common shares attributable to dilutive effect of conversion of debt securities for fiscal 2012 was 0.00 shares, a 100.00% decline from fiscal 2011.
- Bausch Health Companies Inc. incremental common shares attributable to dilutive effect of conversion of debt securities for fiscal 2011 was 12.98M shares.
| Period end | Incremental Common Shares Attributable to Dilutive Effect of Conversion of Debt Securities 3 month | Incremental Common Shares Attributable to Dilutive Effect of Conversion of Debt Securities 6 month | Incremental Common Shares Attributable to Dilutive Effect of Conversion of Debt Securities 9 month | Incremental Common Shares Attributable to Dilutive Effect of Conversion of Debt Securities 12 month |
|---|---|---|---|---|
| 2013-12-31 | 0.00 shares 10-K · filed 2014-02-28 | |||
| 2013-09-30 | 0.00 shares 10-Q · filed 2013-11-01 | 0.00 shares 10-Q · filed 2013-11-01 | ||
| 2013-06-30 | 0.00 shares 10-Q · filed 2013-08-07 | 0.00 shares 10-Q · filed 2013-08-07 | ||
| 2012-12-31 | 0.00 shares 10-K · filed 2014-02-28 | |||
| 2012-09-30 | 307.00K shares 10-Q · filed 2013-11-01 | 0.00 shares 10-Q · filed 2013-11-01 | ||
| 2012-06-30 | 0.00 shares 10-Q · filed 2013-08-07 | 0.00 shares 10-Q · filed 2013-08-07 | ||
| 2011-12-31 | 12.98M shares 10-K · filed 2014-02-28 | |||
| 2011-09-30 | 12.17M shares 10-Q · filed 2012-11-05 | 16.95M shares 10-Q · filed 2012-11-05 | ||
| 2011-06-30 | 17.97M shares 10-Q · filed 2012-08-03 | 19.34M shares 10-Q · filed 2012-08-03 | ||
| 2011-03-31 | 20.72M shares 10-Q · filed 2012-05-04 | |||
| 2010-06-30 | 1.92M shares 10-Q · filed 2011-08-08 | 1.17M shares 10-Q · filed 2011-08-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Braveheart Bio, Inc. (BRVE) | United States | $2.106B | |
| PALVELLA THERAPEUTICS, INC. (PVLA) | United States | $2.105B | -35.55 |
| Trevi Therapeutics, Inc. (TRVI) | United States | $2.091B | -51.93 |
| OCULAR THERAPEUTIX, INC (OCUL) | United States | $2.159B | -7.15 |
| Prestige Consumer Healthcare Inc. (PBH) | United States | $2.163B | 13.03 |
| Generate Biomedicines, Inc. (GENB) | United States | $2.052B | |
| PERRIGO Co plc (PRGO) | Ireland | $2.038B | -0.79 |
| NEKTAR THERAPEUTICS (NKTR) | United States | $2.026B | -9.05 |
| Aurinia Pharmaceuticals Inc. (AUPH) | $2.207B | 7.18 | |
| UroGen Pharma Ltd. (URGN) | $2.015B | -18.42 |